Taiho Pharmaceutical Co., Ltd.

This early-stage study is testing the safety and effectiveness of a new drug, TAS-116, when given alongside the standard drug imatinib. It is for people with advanced gastrointestinal stromal tumors (GIST) whose cancer has continued to grow despite taking imatinib. The goal is to…

This study is testing whether an oral drug called TAS-205 can help slow the progression of Duchenne muscular dystrophy (DMD). It involves about 104 boys and young men with DMD, split into groups based on whether they can still walk. The main goal is to see if the drug improves th…